Which of the following economic reasons explains why real pharmaceuticals in this are higher than other countries? A) Increased use of generic (non branded) pharmaceuticals in the U.S. market B) the presence of demand side monopsony power in the U.S. market C) price elastic demand for pharmaceuticals in the U.S. market D) price inelastic demand for pharmaceuticals in the U.S. market